Changes in peripheral blood during the antiviral treatment with Peg-IFNα-2 a and ribavirin for patients with chronic hepatitis C and the relationship between the changes and effect
10.3760/cma.j.issn.1003-9279.2017.06.014
- VernacularTitle: 慢性丙型病毒性肝炎干扰素抗病毒治疗外周血的变化特征及与疗效关系
- Author:
Zhenzhen LI
1
;
Hongxiao HAO
;
Lu ZHANG
;
Yao LU
;
Weihua CAO
;
Xingyue WANG
;
Chongping RAN
;
Tianlin QI
;
Shuling WU
;
Ge SHEN
;
Ru LIU
;
Min CHANG
;
Leiping HU
;
Minghui LI
;
Yao XIE
Author Information
1. The Second Division of Liver Disease, Liver Center, Beijing Ditan Hospital, Capital Medical University, Beijing, 10015, China
- Publication Type:Journal Article
- Keywords:
Hepatitis C, Chronic;
Peg-IFN α-2a ribavirin peripheral blood cells Hepatitis C virus RNA;
Serum virological response
- From:
Chinese Journal of Experimental and Clinical Virology
2017;31(6):545-548
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the changes of peripheral blood image of chronic hepatitis C (CHC) patients treated with pegylated interferon (Peg-IFN) and ribavirin, and explore the relationship between the changes and serum virological respose (SVR).
Methods:Patients with CHC treated with Peg-IFN α-2 a and ribavirin in the Second Division of Liver Disease in Beijing Ditan Hospital were monitored for peripheral blood cells routine examination and Liver function, kidney function, thyroid function at baseline and week 2, 4, 8, 12, 24, 36, 48, and week 12, 24, 48 after the end of treatment for chronic hepatitis C, and HCV RNA.
Results:The decrease of peripheral blood cell counts began to appear at week 2 of treatment. For CHC patients without cirrhosis, white blood cells, lymphocyte, hemoglobin and platelets at week 2, while minimum values were seen at week 36, and the neutrophils reached the minimum value to at week 24. Significant recovery of the peripheral blood changes was seen at the end of treatment (48 weeks), and reached pre-treatment levels at week 48 after the end of treatment. For CHC patients with cirrhosis, white blood cells, lymphocytes, hemoglobin and platelets significantly decreased at week 2, while neutrophils reached a minimum value at 2 weeks. And hemoglobin and platelets reached a minimum value at 24 weeks, and the white blood cells reached the minimum value at weeks 24-36 besides lymphocyte reached the minimum value at week 36. Significant recovery was seen at the end of treatment (48 weeks), and the blood cell counts reached pre-treatment levels at 48 weeks after the end of treatment. For patients with CHC, hemoglobin decreased by more than 27.47% at week 4, which means that the patient would have a predictive significance for SVR, as well as the of PLT reduction by more than 36.96% at week 8.
Conclusions:During the treatment with Peg-interferon and ribavirin, the variation of blood picture has some predicting effect, which predicts the result of antiviral treatment.
